1. Aukema TS, Valdés Olmos RA, Korse CM, et al. Utility of FDG PET/CT and brain MRI in melanoma patients with increased serum S-100B level during follow-up. Ann Surg Oncol. 2010;17:1657–61.
2. Howard JH, Thompson JF, Mozzillo N, et al. Metastasectomy for distant metastatic melanoma: analysis of data from the first Multicenter Selective Lymphadenectomy Trial (MSLT-I). Ann Surg Oncol. In press.
3. Barth A, Wanek LA, Morton DL. Prognostic factors in 1,521 melanoma patients with distant metastases. J Am Coll Surg. 1995;181:193–201.
4. Atkins MB, Hauschild A, Wahl RL, Balch CM. Diagnosis of stage IV melanoma. In: Balch CM, Houghton AN, Sober AJ, Soong SJ, Atkins MB, Thompson JF, editors. Cutaneous melanoma. 5th ed. St. Louis: Quality Medical Publishing; 2009. p. 573–602.
5. Chapman PB, Hauschild A, Robert C, et al. Improved survival with vemurafinib in melanoma with BRAF V600E mutation. N Engl J Med. 2011:364:2507–16.